while this therapy seems to have limited antitumor activity against nontransitional cell histological cancer , stage tis disease and later development of de novo lesions , the regimen is efficacious in selected patients with advanced urothelial tract transitional cell carcinoma .
C0334227
cell
C0279680
urothelial